UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 10 von 224
Datensatz exportieren als...
BibTeX
biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
The Journal of pathology, 2010-10, Vol.222 (2), p.191-198
Köbel, Martin
Reuss, Alexander
Bois, Andreas du
Kommoss, Stefan
Kommoss, Friedrich
Gao, Dongxia
Kalloger, Steve E
Huntsman, David G
Gilks, C. Blake
2010
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Köbel, Martin
Reuss, Alexander
Bois, Andreas du
Kommoss, Stefan
Kommoss, Friedrich
Gao, Dongxia
Kalloger, Steve E
Huntsman, David G
Gilks, C. Blake
Titel
biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
Ist Teil von
The Journal of pathology, 2010-10, Vol.222 (2), p.191-198
Ort / Verlag
Chichester, UK: John Wiley & Sons, Ltd
Erscheinungsjahr
2010
Quelle
Wiley Online Library Journals Frontfile Complete
Beschreibungen/Notizen
Studies on the p53 expression and outcome for women with ovarian carcinoma have produced conflicting results. The observed heterogeneity may be due to the range of cut-offs used to define overexpression and the mix of histotypes of the study cohorts. We aimed to examine the association between p53 expression and biological properties of tumours as well as outcome in 502 pelvic high-grade serous carcinomas (HGSCs) derived from two population-based cohorts from British Columbia representing cases with or without residual tumour after initial surgery, respectively, and one clinical trial cohort from Germany (AGO-OVAR-3). p53 expression was assessed on tissue microarrays by immunohistochemistry using the DO-7 antibody. p53 expression was scored in three tiers as complete loss of expression, focal expression or overexpression (defined as more than 50% positive tumour cell nuclei) and correlated with survival using multivariate Cox regression models. p53 was completely absent in 30.3%, focally expressed in 12.0%, and overexpressed in 57.7% of HGSCs, which was an inverse pattern compared to clear cell and endometrioid types of ovarian carcinomas, where 76% and 69% of cases showed focal expression, respectively (p < 0.001, chi square test). Pelvic HGSCs show either complete absence of p53 expression or p53 overexpression in 88% of cases; thus, aberrant p53 expression is a ubiquitous feature of HGSCs. HGSCs with p53 overexpression were associated with a reduced risk of recurrence compared to cases with complete absence of p53 in the British Columbia cohort with residual tumour (HR = 0.71, 95% CI 0.51-0.99) and for a combination of all three cohorts (HR = 0.70, 95% CI 0.55-0.89) in multivariate analysis including age, stage, residual tumour, and stratification by cohort. The association of complete absence of p53 expression with unfavourable outcome suggests functional differences of TP53 mutations underlying overexpression, compared to those underlying complete absence of expression. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Sprache
Englisch
Identifikatoren
ISSN: 0022-3417
eISSN: 1096-9896
DOI: 10.1002/path.2744
Titel-ID: cdi_proquest_miscellaneous_907167709
Format
–
Schlagworte
Adult
,
Age
,
Aged
,
Aged, 80 and over
,
Antibodies
,
Biological and medical sciences
,
Biomarkers, Tumor - metabolism
,
carcinoma
,
Cell survival
,
Clear cells
,
Clinical trials
,
Combined Modality Therapy
,
Cystadenocarcinoma, Serous - genetics
,
Cystadenocarcinoma, Serous - metabolism
,
Cystadenocarcinoma, Serous - pathology
,
Cystadenocarcinoma, Serous - therapy
,
Epidemiologic Methods
,
Female
,
Humans
,
Immunohistochemistry
,
Investigative techniques, diagnostic techniques (general aspects)
,
Medical sciences
,
Middle Aged
,
Multivariate analysis
,
Mutation
,
Neoplasm Staging
,
Neoplasm, Residual
,
Nuclei
,
Ovarian carcinoma
,
Ovarian Neoplasms - genetics
,
Ovarian Neoplasms - metabolism
,
Ovarian Neoplasms - pathology
,
Ovarian Neoplasms - therapy
,
p53
,
p53 protein
,
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
,
pelvic
,
Pelvis
,
Prognosis
,
Regression analysis
,
serous
,
Surgery
,
TP53
,
Tumor Suppressor Protein p53 - metabolism
,
Tumors
,
Young Adult
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX